Second malignant neoplasm in treated Hodgkin's disease. Report of a patient and scope of the problem.
The condition of a 6-year-old boy was diagnosed as mixed-cellularity Hodgkin's disease that involved the right side of the neck. Five years after the completion of radiation therapy for the involved area, followed by six courses of chemotherapy with mechlorethamine hydrochloride (nitrogen mustard), vincristine sulfate, procarbazine hydrochloride, and prednisone, he developed cerebral gliosarcoma. Numerous second malignant neoplasms have been reported in adults following treatment for Hodgkin's disease; however, the sequence of events in our patient is a new finding that has not, to our knowledge, been reported previously. While the second malignant tumor may have been induced by prior treatment, direct evidence is lacking.
Takaue
Y
Y
Sullivan
M P
MP
Ramirez
I
I
Cleary
K R
KR
van Eys
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000209:etiology*; D002648:Child; D003131:Combined Modality Therapy; D005910:Glioma / Q000209:etiology*; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology / Q000209:etiology*; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011882:Radiotherapy, High-Energy; D012306:Risk; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone